These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2551168)

  • 21. Risk factors and recurrent patterns in Stage I endometrial cancer.
    DiSaia PJ; Creasman WT; Boronow RC; Blessing JA
    Am J Obstet Gynecol; 1985 Apr; 151(8):1009-15. PubMed ID: 3985062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostically relevant factors in malignant mixed Müllerian tumor].
    Marth C; Koza A; Müller-Holzner E; Hetzel H; Fuith LC; Dapunt O
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):605-9. PubMed ID: 2170227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carcinosarcoma and mixed mesodermal tumors of the uterus: a clinical and pathologic study of 10 cases (author's transl)].
    Genton C; Schreiner WE
    Schweiz Rundsch Med Prax; 1977 Feb; 66(5):134-9. PubMed ID: 189300
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
    Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant Mullerian mixed tumors of the uterus: a study of 21 cases.
    King ME; Kramer EE
    Cancer; 1980 Jan; 45(1):188-90. PubMed ID: 6243241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases.
    Grasso S; Loizzi V; Minicucci V; Resta L; Camporeale AL; Cicinelli E; Cormio G
    Oncology; 2017; 92(4):197-204. PubMed ID: 28092915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH; Chambers JT; Schwartz PE; Cole LA
    Gynecol Oncol; 1990 Dec; 39(3):352-7. PubMed ID: 2175287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant mixed Müllerian tumors of the uterus. Clinical, morphologic and immunohistochemical findings].
    Falk S; Papaikonomou I; Böckler H; Stutte HJ
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):630-4. PubMed ID: 2550312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of recurrence in malignant mixed müllerian tumor of the uterus.
    Spanos WJ; Peters LJ; Oswald MJ
    Cancer; 1986 Jan; 57(1):155-9. PubMed ID: 3000571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant mixed Müllerian tumors of the uterus.
    To WW; Ngan HY
    Int J Gynaecol Obstet; 1994 Oct; 47(1):39-44. PubMed ID: 7813749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases.
    Kaku T; Silverberg SG; Major FJ; Miller A; Fetter B; Brady MF
    Int J Gynecol Pathol; 1992; 11(2):75-88. PubMed ID: 1316323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological features and survival of young Turkish patients with testicular germ cell tumors.
    Ozgun A; Karagoz B; Tuncel T; Emirzeoglu L; Celik S; Bilgi O
    Asian Pac J Cancer Prev; 2013; 14(11):6889-92. PubMed ID: 24377621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.